Introduction Recently, results describing pulmonary vein isolation (PVI) on patients using a robotic navigation system (RNS) in a high-volume center specialized in pulmonary vein isolation were published. The main purpose of this prospective study was to evaluate the learning curve of new users of RNS in a community hospital and to address the effectivity of RNS in electrophysiological settings with fewer patients. Radiation times, procedural times, feasibility, and safety with the RNS were assessed. Methods PVI using the RNS was performed on 100 consecutive patients with symptomatic paroxysmal (n=56, 56%) or persistent atrial fibrillation (AF). To assess the learning curve of practitioners with first-time use of RNS, patients were divided into four groups of 25 patients each (Q1-Q4). Procedural times as well as radiation times, complications, and outcome after a 6-month follow-up period were assessed for each quartile. All patients were ablated by the same physician.
Introduction
Pulmonary vein isolation (PVI) has evolved into an effective treatment strategy for patients with symptomatic drug-refractory atrial fibrillation. However despite several refinements of ablation strategies in the past decade, circumferential isolation of the pulmonary veins remains for the most part operator-dependent, requiring careful skill for optimal catheter navigation [1, 2] . In the search for novel ablation tools to optimize the ablation procedure of PVI, a remote robotic navigation system (RNS, Sensei™ Robotic Catheter System, Hansen Medical, Inc, Mountain View, California) has become available, promising enhanced catheter stability and more precise catheter navigation [3, 4] . Recently, data from a high-volume center mainly focused on PVI (>1,000 PVIs/year, ∼65% of all ablation cases in this hospital) were published, showing comparable results to manual ablation and low complication rates [5] , raising the question whether centers with a smaller volume would be able to obtain similar results. To date, limited data is available regarding the learning experience of ablationists who are introduced to RNS after using only manual ablation for PVI [5] [6] [7] [8] , and to the best of our knowledge no data exists demonstrating the efficacy and learning curve of an electrophysiologic laboratory not focused on pulmonary vein isolation [5] . The main purpose of this prospective study was to depict the learning curve with this system in PVI in a community hospital with a volume of approximately 150 pulmonary vein isolations per year (up to 35% of all ablations in our hospital). In addition to radiation times and procedural times, the effectiveness and safety of the RNS in atrial fibrillation ablation were assessed.
Patients and methods
Pulmonary vein isolation using the RNS was performed in 100 consecutive patients (n=48 [48%] female, mean age 60.2±9.3 years) with symptomatic paroxysmal (n=56, 56%) and persistent (n=44, 44%) drug-refractory atrial fibrillation. Anticoagulation with Phenprocoumon was discontinued at least 5 days before ablation until an INR <2 was reached and low-molecular heparin was administered as a bridging therapy (Enoxaparin with a dose of 0.1 mg/10 kg body weight). All patients were treated with at least one anti-arrhythmic drug before the ablation procedure.
All patients were ablated by the same physician who had previously performed more than 500 pulmonary vein isolations only by manual ablation.
Working with the SENSEI™ robotic navigation system
The RNS (Sensei™ Robotic Catheter System, Hansen Medical, Inc, Mountain View, California) is an electromechanical system comprising a physician workstation ( Fig. 1(a) ) including the instinctive motion controller, the remote robotic arm ( Fig. 1(b) ), and the artisan sheath (Artisan Catheter, Hansen Medical) that consists of an outer (14 F) and an inner sheath (10.5 F), with the possibility to incorporate any 7-French mapping or ablation catheter ( Fig. 1(b) ). Catheter navigation is implemented by four pull wires in the internal sheath providing the opportunity to insert/de-insert or deflect with an angle up to 360°, and two pull wires in the external sheath allowing to insert/de-insert, rotate, and deflect. The steerable sheath system is carried by a remote robotic arm fixed at the X-ray procedure table (Fig. 1(b) ). Navigation of the robotic arm is realized by the instinctive motion controller, which is integrated in the physicians workstation, placed remotely from the patient table ( Fig. 1(a) ). To assure ablation safety, contact force control is provided by the Intellisense™ software with measurement of catheter forces, displayed at the physician workstation.
Three-dimensional mapping (3-D-map)
A three-dimensional map of the left atrium (LA) was performed with the EnSite NavX system (St. Jude Medical, Minneapolis, Minnesota) using a decapolar circular mapping catheter (Lasso, Biosense Webster, Diamond Bar, CA, USA) in all patients and Cohesion software enabled image integration of the 3-D-map into the Hansen workstation. After positioning the circular mapping catheter in the distal part of the pulmonary vein the catheter was withdrawn to the pulmonary vein ostium, which was accurately defined by anatomical (comparison with angiographic anatomy) and electrophysiological criteria and marked with a "catheter shadow" to reliably define the antral part of the PVs. After having displayed all pulmonary veins and the LAA, the left atrium was mapped with the lasso catheter and, if necessary, additional mapping points were assessed with the ablation catheter (Fig. 2) . Transesophageal echocardiography was performed the day before ablation to rule out intracardiac thrombus or pulmonary vein stenoses. After having signed an informed consent patients underwent the ablation procedure in the postabsorptive state and under conscious sedation with midazolam and fentanyl. After having placed a coronary sinus catheter via the left subclavian vein, access for both the transseptal sheath and the artisan sheath (AS) was performed at the right femoral vein. A single-puncture, double transseptal approach was performed in all patients as described recently [9] . A heparin bolus of 3,000 IE was given intravenously and a single transseptal puncture was performed with introduction of a conventional transseptal sheath in the left atrium. One more heparin bolus of 5,000 IE was administered and activated clotting time (ACT) levels were measured every 30 min with a target ACT >300 s. The transseptal sheath was then withdrawn with a guiding-wire left in the LA, and the AS with a 3.5-mm cool-tip ablation catheter (Thermocool Navistar 3.5 mm, irrigated tip, Biosense Webster, Diamond Bar, CA, USA) was manually introduced into the left atrium across the same puncture site. Subsequently, the pulmonary veins were visualized by selective angiography in three projections (posterior-anterior, left anterior oblique 30°, right anterior oblique 30°) to rule out pulmonary vein stenosis prior to ablation and to define the pulmonary vein ostia.
A three-dimensional map of the left atrium was created using the NavX system and integrated into the Hansen workstation by the Cohesion software.
In all patients with paroxysmal and persistent atrial fibrillation circumferential pulmonary vein isolation was realized by encircling both ipsilateral pulmonary veins starting with the two lateral veins and ablating the septal veins thereafter.
In patients with persistent atrial fibrillation and ongoing atrial fibrillation, in addition to pulmonary vein isolation, a stepwise approach as proposed recently [10] was performed, comprising the ablation of a roofline, mitral isthmus line, CAFEs, or coronary sinus ablation. Isolation of the pulmonary veins was assessed by a decapolar Lasso catheter (Lasso, Biosense Webster, Diamond Bar, CA, USA) placed in each pulmonary vein as well as exit block testing. The electrophysiological endpoint of the conduction block of the roof line and the mitral isthmus line was confirmed during sinus rhythm using pacing maneuvers as previously described [11, 12] . In both patient groups radiofrequency (RF) delivery at each point was limited to a maximum duration of 30 s depending on abolition of local electrograms or disappearance of local PV potentials during RF application. Power was limited to 25 W at the posterior wall and 30 W at the anterior aspect of the LA. With the aid of Intellisense software the distal pressure levels were measured and a maximum pressure of 30 g was accepted; otherwise the auto-retract function was used to lower the catheter tip force and to reposition the ablation catheter.
Assessment of learning curve
To assess the learning curve of use of RNS 100 patients were divided into quartiles of 25 patients each. The quartiles were compared as follows: quartile 1 (Q1, pts 1-25) vs quartile 2 (Q2, pts 26-50), quartile 3 (Q3, pts 51-75) vs quartile 4 (Q4, pts 76-100), Q1 vs Q4 and Q2 vs Q3. The learning curve was assessed by: a. Focusing on procedural and radiation times; these times were divided as follows: radiation time into "radiation time of ablation procedure" and "overall radiation time", procedural time into "time of ablation procedure" (i.e., time from start of ablation to last ablation) and "overall procedural time". b. In addition to the primary ablation outcome, incidence of complications as well as the outcome at a 6-month follow-up was evaluated.
3 Follow-up
Follow-up was performed in all patients with 24-h holter recordings before hospital discharge and with 7-day holter recordings after a 3-and 6-month follow-up period. If symptoms indicative for recurrence of atrial fibrillation were present, the patients received an event recorder for further assessment of atrial fibrillation recurrence.
To rule out pulmonary vein stenoses and left atrial thrombus, TEE was performed before discharge and after a 6-month follow-up period.
A successful ablation procedure was defined as the absence of symptoms and atrial fibrillation episodes in 7-day holter recordings (or event recorder) after a 3-month blanking period. According to the proposed criteria for the definition of atrial fibrillation episodes, atrial fibrillation is defined as an arrhythmic episode of at least 30 s [13] . Furthermore, patients were classified as either asymptomatic on anti-arrhythmic drugs, or off anti-arrhythmic drugs, at the time of the follow-up (Fig. 3) .
Statistical analysis
Statistics were calculated using the Statistical Package for the Social Sciences (SPSS software-version 11.0, Chicago, IL, USA). All values are expressed as mean ± standard deviation or median (range). Continuous data were compared using student t test or Mann-Whitney U test and categorical variables using Chi-square analysis or Fisher exact test when appropriate. A p value <0.05 was considered statistically significant.
Six-months Follow-up

Results
A total of 100 patients were divided into four groups with 25 patients in each group. Patients in all four groups were comparable with regard to baseline characteristics such as age, incidence of coronary heart disease, hyperlipidemia, diabetes mellitus, or incidence of paroxysmal or persistent atrial fibrillation (Table 1 ). Significant differences of left atrial diameter were seen between patients of group 3 and group 4 (43.7±7.1 vs 49.7±5.6, p=0.01) and a significant higher incidence of hypertension was seen in group 4 when compared to group 1 (n=18 (72%) vs n=10 (40%), p=0.02).
Primary ablation outcome
Pulmonary vein isolation was performed in 98/100 (98%) patients by robotic navigation alone, but in 2/100 (2%) patients (all of group 1) with persistent atrial fibrillation a switch to manual ablation was necessary to successfully isolate the right inferior pulmonary veins. In these two patients isolating the right inferior pulmonary veins was successfully performed with manual catheter ablation. A stepwise approach with ablation of additional lines or ablation within the coronary sinus was performed in patients with ongoing persistent atrial fibrillation only. All intended additional lines were ablated successfully with the RNS (Table 2) . Overall, ablation of the roof line on 21 patients and on 12 patients ablation of the mitral isthmus line was performed successfully. There were no significant differences between the four groups with regard to the ablation of additional lines or manually performed coronary sinus ablation (Table 2 ). Overall, in six patients manual ablation was performed; whereas in two patients pulmonary vein isolation was not successful with the RNS alone (see above), in four patients manual ablation of the coronary sinus was performed during a stepwise approach (see Section 2 for details).
Learning effect
The comparison of procedural and radiation times of the different quartiles is depicted in Table 2 .
Comparing the median times of Q1 with Q2 a significant reduction of ablation time, overall fluoroscopy time and fluoroscopy time for ablation was seen; the comparison of Q2 with Q3 showed a significant reduction of procedural times as well as radiation times although there were no significant differences in age, cardiovascular risk factors, or in the incidence of paroxysmal or persistent atrial fibrillation. When comparing Q2 with Q3 no further significant reduction of ablation time was observed whereas overall procedural time, overall fluoroscopy time and fluoroscopy time for ablation were still improved (Table 2) . Importantly, the comparison of Q3 with Q4 showed no further significant reduction of overall procedural times or fluoroscopy times (Table 2 ). Overall radiation times of group 4 were significantly higher when compared to group 3 but in patients of group 4 ablation of roof lines was significantly more often performed than in patients of group 4 (n=3 (12%) vs n=9 (36%), p=0.047; Table 2 ). No clinically evident cerebral ischemia or other peripheral embolism was found in any patient of the four groups. No pulmonary vein stenoses were detected by TEE at the 6-month FU. One pericardial tamponade was seen in the course of 100 ablations (1%) and occurred at the end of the ablation procedure in a patient with paroxysmal atrial fibrillation of group 3. The effusion was not the result of left atrial perforation but rather due to inflammation process caused by ablation, as the hemoglobin value of pericardial effusion was below 4 g/dl. After immediate pericardiocentesis with retraction of 200 ml of hemorrhagic fluid the hemodynamic compromise resolved within minutes. Conservative management resulted in complete recovery without sequelae and no effusion was evident after 6 days.
Follow-up
An overall success rate of 74% (n=74/100) was achieved at the 6-month follow-up. The success rate of patients with paroxysmal atrial fibrillation was 83.9% (n=47/56) and 61.4% (n=27/44) in patients with persistent atrial fibrillation after 6 months. Thirty-one of hundred patients (31%) were on antiarrhythmic drugs at the time of the 6-month follow-up (n=11 [19.6%] patients with paroxysmal atrial fibrillation (AF) and n=20 [45.5%] patients with persistent AF; Fig. 3) .
Comparing the success rate of the four quartiles at the 6-month FU, a non-significant trend to higher success rates was seen in the course of group1 to group 3 (Table 3) .
During the follow-up period in 3/44 patients (6.8%) with persistent atrial fibrillation and in 1/56 patient (1.7%) with paroxysmal atrial fibrillation an early redo procedure (within 3 months) was necessary. These patients presented highly symptomatic left atrial tachycardia involving the roof line in one patient, implying a gap in the circular lesion around the PVs in two patients and a focal atrial tachycardia at the anterior left atrial wall in one patient.
Discussion
What benefits can be earned?
The present study demonstrates that (1) the learning curve of new users of RNS on patients with PVI is steep and achieving an appropriate level of competence with the system can be reached even in a community hospital after experience with only 75 patients; (2) a significant reduction of overall fluoroscopy time is reached after a short learning experience (Fig. 4) ; and (3) the implementation of a RNS in a community hospital is useful and the results comparable to high-volume centers.
How fast is it learned?
First, the overall procedural time was significantly reduced in the course of this study of 100 patients ( Table 2) . These results remain conflicting, as a reduction of procedure-related times was found in some studies [5, 7, 8] , whereas other investigators have reported no significant reduction of procedural time/ablation times during their learning experience [14] .
Comparing the procedural times in this series with those of a recently published study from a high-volume ablation center, mean procedural times were longer [5] . Therefore, it remains unclear whether the procedural time might be further shortened after more experience is gained.
Importantly, a significant reduction of the fluoroscopy time was found in our study when comparing the first 25 patients in group 1 with the last patients in group 4. The reduction of fluoroscopy time obviously was related to the use of the navigation system, as not only the "overall radiation time" but also the "radiation time of ablation procedure" was significantly reduced and both patient groups were similar with regard to atrial fibrillation type, incidence of comorbidities, and left atrial size (Table 1) .
Comparing the fluoroscopy times of the last group (Q4), radiation times close to those of high-volume ablation centers were reached (see reference [5] ). This reflects the value a remote robotic navigation system brings to a Q1 quartile 1 (pts 1-25), Q2 quartile 2 (pts 26-50), Q3 quartile 3 (pts 51-75), Q4 quartile 4 (pts 76-100), AAD ongoing antiarrhythmic drug therapy at 6-month follow-up, AF atrial fibrillation community hospital; clearly the benefits with regard to fluoroscopy reduction seem to be high. Noteworthy, when comparing the four quartiles, a continuous learning effect was seen within the first three quartiles (Q1-Q3, Table 2 ) with significant reduction of both, the procedural and radiation times. Whereas procedural times, overall fluoroscopy times, and fluoroscopy times of ablation showed continual improvement as seen in the comparison of Q3 with Q2 no further improvement was seen between Q4 and Q3 (Table 2) . Therefore, reduction of fluoroscopy times in this study reached a plateau after 75 patients, whereas other investigators in high-volume centers have described a plateau after 50 patients [8] . A significant difference of left atrial diameter and a higher rate of ablation of roof lines between groups 3 and 4 might have influenced the slightly increased fluoroscopy times between group 4 and group 3. Nonetheless, this indicates that about 75 patients are needed for an effective learning period for a community hospital to reach similar fluoroscopy times characteristic of high-volume centers (reference [5] ).
Primary ablation outcome and efficacy
These data show that the endpoint of PVI could be reached by robotic manipulation alone in the vast majority (98%) of patients. Only in the first patient group (in the first five patients) a switch to the manual approach was necessary for isolating the right pulmonary veins.
With regard to the efficacy of the system we found an overall success rate of 74% after a 6-month follow-up period in patients with paroxysmal and persistent atrial fibrillation. Considering the patients with paroxysmal atrial fibrillation only, the success rate was even higher with 83.9% freedom of atrial fibrillation. This demonstrates a high success rate for patients with paroxysmal atrial fibrillation when the RNS is used for pulmonary vein isolation which is at least comparable to success rates reported by high-volume centers focused on pulmonary vein isolation [5] .
Comparison of the success rate of patients in the different quartiles
To evaluate the impact of the learning experience on the outcome, the success rate of the four groups was compared at a 6-month follow-up. There were no significant differences of the success rates of the four groups at this time. Importantly there was a trend to higher success rates in groups 2 and 3, when compared to group 1 (not significant). Potentially, there might be significant differences after a longer follow-up period. Nonetheless, this reflects improvement affecting not only procedural and radiation times but also effectivity when using the RNS in a community hospital after a short learning experience.
Safety aspects
There is cause for concern that the lack of manual perception caused by "joystick navigation" might raise the risk for complications such as perforation of the left atrial wall resulting in pericardial effusion or even pericardial tamponade. As the superior part of the LA usually is thin and therefore more vulnerable than other regions of the LA, ablation of additional lines such as a roofline raises concern of perforation, particularly when the ablation catheter is perpendicular to the LA roof. Recently, the role of catheter pressure on size, transmurality and safety of the lesions using the RNS was evaluated [15, 16] . According to their data, contact pressure of 20-30 g and power up to 40 W seems to be both effective and safe. Hence the ablation settings used in the present study were balanced for a safe but effective ablation. With the aforementioned power setting of 25 W at the posterior wall and 30 W at the anterior wall, a maximum pressure of 20-30 g was tolerated during the ablation procedure. In the case of higher pressure values transmitted by the Intellisense™ system, RF application was stopped immediately and the ablation site was optimized via discrete catheter movement or using the Patients, (n) Radiation times (min) Fig. 4 Radiation times of all patients displayed as diagram "auto-retract function". In these patients one pericardial effusion (n=1/100, 1%) occurred resulting in pericardial tamponade requiring pericardial puncture and drainage. This complication rate is comparable to the data of a highvolume center recently published [5] .
Study limitations
These data reflect the learning effect and reduction of procedural and fluoroscopy times in a patient group where only RNS was used; therefore a comparison to a manual approach is not possible with this study design. In addition, the ablationist performing the pulmonary vein isolation in these patients was relatively experienced with manual PVI before starting ablation with the RNS. Therefore, when interpreting the results of this study, the experience of a single operator whose skills sets may not be generalized to other operators has to be considered.
Conclusion
This study demonstrates the learning curve with the robotic navigation system is steep and a significant reduction of procedural and radiation times can be achieved during the learning experience. This provides an important and strong indication that RNS is a safe and effective ablation tool for treatment of atrial fibrillation. Our results show, that RNS is feasible and safe when performed in a community hospital with similar success and complication rates as compared to high-volume centers.
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